Ahmedabad-based Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Erythromycin Tablets USP, 250 mg and 500 mg a generic equivalent of US reference listed drug, Erythromycin Tablets
Read More
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Isotretinoin Capsules. The drug will be manufactured at the group’s formulation manufacturing facility in Moraiya, Ahmedabad (India)
Read More
As per the US Food and Drug Administration (USFDA), Glenmark Pharmaceuticals is in the process of recalling 1,200 bottles of a generic drug which is used in the treatment of high blood pressure, in the US market due to a manufacturing fault
Read More
Gland Pharma informed that the USFDA inspected the Pashamylaram Facility at Hyderabad from 23 August 2023 to 26 August 2023
Read More
The drug is indicated to treat a certain lung disease called idiopathic pulmonary fibrosis (IPF). As per the company's statement, this product will be manufactured at Lupin’s Pithampur facility in India
Read More
In the latest drug alert for the month of July, the Central Drug Standard Control Organisation (CDSCO) has flagged as many as 51 drug formulations from top pharma giants such as Cipla, Sun Pharma and Alkem Health Science among others.
Read More
Ipca Laboratories on Thursday informed the exchanges that its Piparia (Silvassa) formulations manufacturing facility has received the status "Voluntary Action Indicated (VAI)" from USFDA after the regulator had conducted an inspection on the unit from 18th April 2023 to 26th April 2023.
Read More
On Thursday, Torrent Pharmaceuticals informed in an exchange filing that it has received the green light from USFDA for its manufacturing facility in Dahej, Gujarat. The manufacturing site was inspected by the USFDA from 17-May-23 to 25-May-23
Read More
